Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature-Reference-Cited by-同舟云学术

Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature

Published:2015-12-18 Issue:8 Volume:17 Page:1041-1053
ISSN:1618-7598
Container-title:The European Journal of Health Economics
language:en
Short-container-title:Eur J Health Econ

Author:

Epstein David,García-Mochón Leticia,Kaptoge Stephen,Thompson Simon G.

Funder

European Commision

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics, Econometrics and Finance (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s10198-015-0753-2.pdf

Reference47 articles.

1. Leal, J., Luengo-Fernandez, R., Gray, A., Petersen, S., Rayner, M.: Economic burden of cardiovascular diseases in the enlarged European Union. Eur. Heart J. 27(13), 1610–1619 (2006)

2. Goff Jr, D.C., Lloyd-Jones, D.M., Bennett, G., Coady, S., D’Agostino, R.B., Gibbons, R., et al.: ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2), S49–S73 (2014). doi: 10.1161/01.cir.0000437741.48606.98 . (Epub 2013 Nov 12)

3. Stone, N.J., Robinson, J.G., Lichtenstein, A.H., Bairey Merz, C.N., Blum, C.B., Eckel, R.H., et al.: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2), S1–S45 (2014). doi: 10.1161/01.cir.0000437738.63853.7a . (Epub 2013 Nov 12)

4. Eckel, R.H., Jakicic, J.M., Ard, J.D., de Jesus, J.M., Houston Miller, N., Hubbard, V.S., et al.: 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129(25 Suppl 2), S76–S99 (2014). doi: 10.1161/01.cir.0000437740.48606.d1 . (Epub 2013 Nov 12)

5. Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, M., et al.: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33(13), 1635–1701 (2012)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Universal Cardiovascular Disease Risk Assessment in Pregnancy;JACC: Advances;2024-08

2. Cost-effectiveness of applying high-sensitivity troponin I to a score for cardiovascular risk prediction in asymptomatic population;PLOS ONE;2024-07-19

3. Optimizing cardiovascular disease risk screening in a low-resource setting: cost-effectiveness of program modifications in Sri Lanka modelled with nationally representative survey data;BMC Public Health;2023-09-15

4. A cost-effectiveness analysis of risk-based intervention for prevention of cardiovascular diseases in IraPEN program: A modeling study;Frontiers in Public Health;2023-02-24

5. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease;The European Journal of Health Economics;2022-10-14